The U.S. IPO market has recovered from its slump but remains uneven, with investors pressing issuers on revenue durability, profitability and valuation, according to Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers. Bellin told Crunchbase News that a good year for traditional U.S. IPOs runs between 125 and 175 deals, while the year to date has produced just under 90. He described the market as healthy in breadth, with industrial products, tech, consumer, energy, utilities and some financial services all returning to list.

Momentum has nonetheless slowed sharply since September and October. Bellin attributed the pause to macroeconomic uncertainty around rates, inflation and geopolitics, along with valuations that some issuers were asking for and that the market judged too rich. Many issuers chose to wait for another window rather than reprice, he said. Bellin characterized the market as selective rather than closed, with quality issuers that are prepared and carry the right story and metrics still able to complete deals.

Investors, Bellin said, are focused on durable revenue backed by strong and diverse customers and a growing base, along with visible backlog demand for an issuer's products or services. Leverage is the other major test: companies carrying significant debt face questions about whether they can take on new leverage that creates profitable value or refinance existing debt at higher rates. Entering the public markets with a reasonable leverage ratio, or explaining through the equity story how invested debt capital generates returns, makes a significant difference, he said.

Scale matters as well. Companies with scale in revenue or assets, depending on the sector, can effectively choose their window and perform well, Bellin said. Smaller, midmarket and smaller-cap companies outside life sciences and biotech have had a harder time. Issuers growing at the right rate with the right metrics can still access the market, but those at the lower end of the scale spectrum may find their opportunities limited.

On artificial intelligence, Bellin said investors are not skeptical of AI itself but of spending without visibility into future earnings and revenue durability. The market is separating AI companies with visible demand from those with only a narrative, he said, and cash generation and profitability are central, whether measured by GAAP income, EBITDA, cash flow or free cash flow. He said the current period of development and growth is unprecedented and that the market will distinguish companies worthy of being public from those that are not.

Bellin said current conditions signal selectivity, noting that some IPO entrants have been big winners while others have traded poorly after issuance. Companies coming to market must be careful about valuation and pricing, he said, because aggressive pricing can lead to post-IPO trading declines that affect those metrics. He also pointed to renewed interest in SPACs and a biotech resurgence.

More company and startup news from TechManNews.